知镜 Cognispect · 医学文献与研究工作台

Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort.

Carbayo Á, Turon-Sans J, Alcolea D, Cortés-Vicente E, Cabezas-Torres M, Alvarez-Sanchez E, Muñoz L, Rubio-Guerra S, García-Castro J, Selma-González J, Bernal S, Gonzalez-Quereda L, Bejanin A, Aranha MR, Santos-Santos M, Belbin O, Vesperinas-Castro A, Collet-Vidiella R, Caballero-Ávila M, Llansó L, Querol L, Lleó A, Fortea J, Gelpí E, Dols-Icardo O, Illán-Gala I, Rojas-Garcia R.
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026-08-01 · PMID 42658841

文献摘要

Introduction Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) constitute a clinico-genetic-neuropathological continuum with marked heterogeneity. Reliable in vivo biomarkers of the disease are lacking. Large, multimodal cohorts are needed to advance biomarker discovery and precision medicine. Methods We describe the structure and results derived from the Sant Pau Initiative on Neurodegeneration (SPIN)-ALS-FTLD subcohort, a longitudinal, multimodal platform that integrates clinical, cognitive, genetic, biofluid, neuroimaging, and neuropathological data within a unified framework embedded in routine care. Results The cohort includes over 1000 participants, 800 blood, 400 CSF, and 800 DNA samples, neuroimaging in over 250 cases, and 66 neuropathological studies. Harmonized longitudinal data and biospecimen collection have enabled substantial clinical, molecular, and translational research output. Discussion SPIN-ALS-FTLD extends the original SPIN framework to the ALS-FTLD continuum, enabling deep phenotyping and multimodal biomarker discovery. This scalable model supports patient stratification, longitudinal monitoring, and the development of precision medicine approaches in neurodegenerative diseases.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。